| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
General Counsel
1 company
Mary Elizabeth Conlon last filed a Form 4 in April 2025, as General Counsel at BTMD. Mary Elizabeth Conlon's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 140,393 shares of BTMD. The BTMD filings lean toward selling, a net 17,107 shares.
Mary Elizabeth Conlon has 11 Form 4 filings on record from May 2022 to April 2025, all as General Counsel at biote (BTMD), 2022–2025.
The 11 reported transactions were 5 option or other derivative awards, 4 option exercises and 2 open-market sales.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $105K.
The largest open-market sale was 10,867 shares of BTMD at an average $5.92 on April 4, 2023, about $64K. Twelve months later BTMD was up 2%.
Neither of the two sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
Shares as reported in the last Form 4 for each company; the most recent is from April 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.